# Renal Function After Stentgraft Treatment Of Abdominal Aortic Aneurysm

Study · id `cardio:ct-nct04754659` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04754659](<https://clinicaltrials.gov/study/NCT04754659>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04754659

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 252 participants.

## Technical summary

Registry record NCT04754659. Randomized; triple masking; primary purpose treatment. Start 2022-12-19 (actual); primary completion 2025-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 252 participants (planned count; ClinicalTrials.gov record NCT04754659, source copy `cardio:ctgov-nct04754659-2024-05-07`, retrieved 2026-11-18)
- Started: 2022-12-19 (actual) (ClinicalTrials.gov record NCT04754659, source copy `cardio:ctgov-nct04754659-2024-05-07`, retrieved 2026-11-18)
- Primary completion: 2025-12 (anticipated) (ClinicalTrials.gov record NCT04754659, source copy `cardio:ctgov-nct04754659-2024-05-07`, retrieved 2026-11-18)
- Completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT04754659, source copy `cardio:ctgov-nct04754659-2024-05-07`, retrieved 2026-11-18)
- Countries: Sweden (ClinicalTrials.gov record NCT04754659, source copy `cardio:ctgov-nct04754659-2024-05-07`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04754659-2024-05-07`, retrieved 2026-11-18)

## The registry's words

- Brief title: Renal Function After Stentgraft Treatment Of Abdominal Aortic Aneurysm
- Acronym: RENOFIX
- Condition: Aortic Aneurysm, Abdominal
- Condition: Renal Insufficiency
- Condition: Stent-Graft Thrombosis
- Intervention (Device): Stentgraft
- Lead sponsor: Vastra Gotaland Region
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Abdominal aortic aneurysm (`cardio:abdominal-aortic-aneurysm`)
- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: Vastra Gotaland Region (`cardio:org-vastra-gotaland-region`)

## Provenance

Content hash: b517b37ca4e5270ec1ae89f17cf43d8881343ed6fdd17ce4e0e6ef37e9fc0bf3
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
